P.M.A. Calverley
- Management of Chronic Obstructive Pulmonary Disease
Edited by N.M. SiafakasBook | Published in 2006DOI: 10.1183/1025448x.erm3806ISBN (electronic): 978-1-904097-82-2 - Lung Function Testing
Edited by R. Gosselink and H. StamBook | Published in 2005DOI: 10.1183/1025448x.erm3105ISBN (electronic): 978-1-904097-89-1 - Table 1. –By P.M.A. Calverley and D. GeorgopoulosBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
- Table 2. –By P.M.A. Calverley and D. GeorgopoulosBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
- Table 3. –By P.M.A. Calverley and D. GeorgopoulosBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
- Table 4. –By P.M.A. Calverley and D. GeorgopoulosBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
- The clinical usefulness of spirometric informationBy P.M.A. CalverleyP.M.A. CalverleyClinical Science Centre, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK. E-mail:
- Modern treatment of chronic obstructive pulmonary diseaseBy P.M.A. Calverley
- Medical therapy for COPD: lessons from the real worldBy P.M.A. Calverley
- Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International SurveyBy S. Rennard, M. Decramer, P.M.A. Calverley, N.B. Pride, J.B. Soriano, P.A. Vermeire and J. VestboS. RennardM. DecramerP.M.A. CalverleyN.B. PrideJ.B. SorianoP.A. Vermeire
- From the AuthorsBy S.I. Rennard, M. Decramer, P.M.A. Calverley, N.B. Pride, J.B. Soriano, P.A. Vermeire and J. VestboS.I. RennardM. DecramerP.M.A. CalverleyN.B. PrideJ.B. SorianoP.A. Vermeire
- Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsBy P.W. Jones, L.R. Willits, P.S. Burge and P.M.A. CalverleyP.W. JonesL.R. WillitsP.S. Burge
- Respiratory failure in chronic obstructive pulmonary diseaseBy P.M.A. Calverley
- Detection of expiratory flow limitation in COPD using the forced oscillation techniqueBy R.L. Dellacà, P. Santus, A. Aliverti, N. Stevenson, S. Centanni, P.T. Macklem, A. Pedotti and P.M.A. CalverleyR.L. Dellacà1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaP. Santus1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaA. Aliverti1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaN. Stevenson1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaS. Centanni1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaP.T. Macklem1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaA. Pedotti1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, CanadaP.M.A. Calverley1TBMLab, Dipartimento di Bioingegneria, Politecnico di Milano University and 2Respiratory Unit, Institute of Lung Disease, San Paolo Hospital, University of Milan, Milan, Italy. 3University Hospital Aintree, University Dept of Medicine, Liverpool, UK. 4Respiratory Division, Meakins-Christie Laboratories, MUHC Research Institute, McGill University, Montreal, Canada
- Impact of preventing exacerbations on deterioration of health status in COPDBy S. Spencer, P.M.A. Calverley, P.S. Burge and P.W. JonesS. SpencerP.M.A. CalverleyP.S. Burge
- Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?By P.M.A. Calverley and S.I. Rennard
- Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDBy W.T. McNicholas, P.M.A. Calverley, A. Lee and J.C. EdwardsW.T. McNicholasP.M.A. CalverleyA. Lee
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperBy B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, A. Fein, J. Heffner, S. Lareau, P. Meek, F. Martinez, W. McNicholas, J. Muris, E. Austegard, R. Pauwels, S. Rennard, A. Rossi, N. Siafakas, B. Tiep, J. Vestbo, E. Wouters and R. ZuWallackB.R. CelliW. MacNeeA. AgustiA. AnzuetoB. BergA.S. BuistP.M.A. CalverleyN. ChavannesT. DillardB. FahyA. FeinJ. HeffnerS. LareauP. MeekF. MartinezW. McNicholasJ. MurisE. AustegardR. PauwelsS. RennardA. RossiN. SiafakasB. TiepJ. VestboE. Wouters
- From the authorBy P.M.A. Calverley
- Candidate genes for COPD in two large data setsBy P.S. Bakke, G. Zhu, A. Gulsvik, X. Kong, A.G.N. Agusti, P.M.A. Calverley, C.F. Donner, R.D. Levy, B.J. Make, P.D. Paré, S.I. Rennard, J. Vestbo, E.F.M. Wouters, W. Anderson, D.A. Lomas, E.K. Silverman and S.G. PillaiP.S. BakkeG. ZhuA. GulsvikX. KongA.G.N. AgustiP.M.A. CalverleyC.F. DonnerR.D. LevyB.J. MakeP.D. ParéS.I. RennardJ. VestboE.F.M. WoutersW. AndersonD.A. LomasE.K. Silverman
- Avoiding backward steps in COPD: looking again at roflumilastBy E.D. Bateman, K.F. Rabe, P.M.A. Calverley, U.M. Goehring, M. Brose, D. Bredenbröker and L. FabbriE.D. BatemanK.F. RabeP.M.A. CalverleyU.M. GoehringM. BroseD. Bredenbröker
- Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation historyBy E.D. Bateman, K.F. Rabe, P.M.A. Calverley, U.M. Goehring, M. Brose, D. Bredenbröker and L.M. FabbriE.D. BatemanK.F. RabeP.M.A. CalverleyU.M. GoehringM. BroseD. Bredenbröker
- Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyBy C.R. Jenkins, B. Celli, J.A. Anderson, G.T. Ferguson, P.W. Jones, J. Vestbo, J.C. Yates and P.M.A. CalverleyC.R. JenkinsB. CelliJ.A. AndersonG.T. FergusonP.W. JonesJ. VestboJ.C. Yates
- Cardiovascular and metabolic effects of CPAP in obese men with OSABy S.R. Coughlin, L. Mawdsley, J.A. Mugarza, J.P.H. Wilding and P.M.A. CalverleyArticle | Published in 2007 in European Respiratory JournalS.R. CoughlinL. MawdsleyJ.A. MugarzaJ.P.H. Wilding
- Roflumilast with long-acting β2 agonists for COPD: influence of exacerbation historyBy E.D. Bateman, K.F. Rabe, P.M.A. Calverley, U.M. Goehring, M. Brose, D. Bredenbröker and L. FabbriArticle | Published in 2011 in European Respiratory JournalE.D. BatemanK.F. RabeP.M.A. CalverleyU.M. GoehringM. BroseD. Bredenbröker
- Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyBy C.R. Jenkins, B. Celli, J.A. Anderson, G.T. Ferguson, P.W. Jones, J. Vestbo, J.C. Yates and P.M.A. CalverleyArticle | Published in 2011 in European Respiratory JournalC.R. JenkinsB. CelliJ.A. AndersonG.T. FergusonP.W. JonesJ. VestboJ.C. Yates
- Expiratory flow-limitation detected by forced oscillation and negative expiratory pressureBy R.L. Dellacà, N. Duffy, P.P. Pompilio, A. Aliverti, N.G. Koulouris, A. Pedotti and P.M.A. CalverleyArticle | Published in 2006 in European Respiratory JournalR.L. DellacàN. DuffyP.P. PompilioA. AlivertiN.G. KoulourisA. Pedotti
- Effect of bronchodilation on expiratory flow-limitation and resting lung mechanics in COPDBy R.L. Dellacà, P.P. Pompilio, P.P. Walker, N. Duffy, A. Pedotti and P.M.A. CalverleyArticle | Published in 2009 in European Respiratory JournalR.L. DellacàP.P. PompilioP.P. WalkerN. DuffyA. Pedotti
- Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsBy C. Crim, P.M.A. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, L.R. Willits, J.C. Yates and J. VestboArticle | Published in 2009 in European Respiratory JournalC. CrimP.M.A. CalverleyJ.A. AndersonB. CelliG.T. FergusonC. JenkinsP.W. JonesL.R. WillitsJ.C. Yates
- Candidate genes for chronic obstructive pulmonary disease in two large data setsBy P.S. Bakke, G. Zhu, A. Gulsvik, X. Kong, A.G.N. Agusti, P.M.A. Calverley, C.F. Donner, R.D. Levy, B.J. Make, P.D. Paré, S.I. Rennard, J. Vestbo, E.F.M. Wouters, W. Anderson, D.A. Lomas, E.K. Silverman and S.G. PillaiArticle | Published in 2010 in European Respiratory JournalP.S. BakkeG. ZhuA. GulsvikX. KongA.G.N. AgustiP.M.A. CalverleyC.F. DonnerR.D. LevyB.J. MakeP.D. ParéS.I. RennardJ. VestboE.F.M. WoutersW. AndersonD.A. LomasE.K. Silverman
- Candidate genes for chronic obstructive pulmonary disease in two large data setsBy P.S. Bakke, G. Zhu, A. Gulsvik, X. Kong, A.G.N. Agusti, P.M.A. Calverley, C.F. Donner, R.D. Levy, B.J. Make, P.D. Paré, S.I. Rennard, J. Vestbo, E.F.M. Wouters, W. Anderson, D.A. Lomas, E.K. Silverman and S.G. PillaiArticle | Published in 2010 in European Respiratory JournalP.S. BakkeG. ZhuA. GulsvikX. KongA.G.N. AgustiP.M.A. CalverleyC.F. DonnerR.D. LevyB.J. MakeP.D. ParéS.I. RennardJ. VestboE.F.M. WoutersW. AndersonD.A. LomasE.K. Silverman
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
